GlaxoSmithKline Expands Patent Dispute with Pfizer to Unified Patent Court
Overview: GlaxoSmithKline (GSK) has escalated its ongoing patent dispute with Pfizer by filing a lawsuit at the Unified Patent Court (UPC). This development marks a notable instance ...
Overview: GlaxoSmithKline (GSK) has escalated its ongoing patent dispute with Pfizer ...
